Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Shares Issued (2024 - 2025)

Xilio Therapeutics (XLO) has disclosed Shares Issued for 2 consecutive years, with $1000.0 as the latest value for Q4 2025.

  • Quarterly Shares Issued rose 103.45% to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $10000.0 through Dec 2025, up 100.0% year-over-year, with the annual reading at $10000.0 for FY2025, 100.0% up from the prior year.
  • Shares Issued hit $1000.0 in Q4 2025 for Xilio Therapeutics, down from $4000.0 in the prior quarter.
  • In the past five years, Shares Issued ranged from a high of $4.3 million in Q1 2024 to a low of -$4.3 million in Q2 2024.